Canada Pension Plan Investment Board’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-60,300
Closed -$5.6M 1651
2021
Q4
$5.6M Buy
+60,300
New +$3.97M 0.01% 683
2018
Q1
Sell
-20,880
Closed -$709K 1310
2017
Q4
$709K Buy
+20,880
New +$595K ﹤0.01% 1007
2016
Q2
Sell
-3,700
Closed -$73K 1178
2016
Q1
$73K Sell
3,700
-7,580
-67% -$121K ﹤0.01% 1080
2015
Q4
$214K Buy
11,280
+450
+4% +$9.18K ﹤0.01% 1004
2015
Q3
$207K Buy
10,830
+2,910
+37% +$98.8K ﹤0.01% 1042
2015
Q2
$367K Buy
7,920
+940
+13% +$40.8K ﹤0.01% 979
2015
Q1
$305K Sell
6,980
-41,270
-86% -$1.92M ﹤0.01% 999
2014
Q4
$1.67M Buy
48,250
+6,270
+15% +$255K 0.01% 802
2014
Q3
$1.76M Buy
41,980
+32,660
+350% +$1.46M 0.01% 748
2014
Q2
$546K Buy
+9,320
New +$587K ﹤0.01% 875

Canada Pension Plan Investment Board's ARNA Position: Q1 2022 in Review

Canada Pension Plan Investment Board sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 60,300 shares — an estimated $5.6M sold.

Canada Pension Plan Investment Board first reported a position in ARNA in Q2 2014 and held it in 10 quarters. The position peaked at $5.6M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Canada Pension Plan Investment Board reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 60,300 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5.6M.
  • Canada Pension Plan Investment Board first reported a position in Arena Pharmaceuticals Inc in Q2 2014 and held it in 10 quarters.
  • Canada Pension Plan Investment Board's Arena Pharmaceuticals Inc position peaked at $5.6M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2022, filed 13 May 2022.